EAH - Ticker AI Digest

Eco Animal Health Group Plc 📰 1
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Eco Animal Health Group Plc in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
EAH Data 2024-12-02 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (EAH) 1
EAH 11:31
Eco Animal Health Group Plc
Share Purchase by Executive Director
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
EAH 06:01
Eco Animal Health Group Plc
Results for the Six Months Ended 30 September 2024
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
Here is a summary of the financial report for Eco Animal Health Group plc for the six months ended September 30, 2024
Performance Highlights
Group revenue decreased by 13% to £33.2 million, with a 9% decrease on a constant currency basis.
Gross margins remained relatively stable at 40.3%, compared to 40.8% in the previous year.
Adjusted <mark style="background-coloryellow">EBIT</mark>DA stood at £0.4 million, down from £0.7 million in the same period last year.
Loss per share was 2.50p, compared to a loss per share of 1.93p in the first half of 2023.
Cash generated by operations before working capital increased to £0.8 million.
Cash balances decreased to £18.3 million.
Operational Highlights
Revenue in the USA and Canada increased by 5% to £8.6 million.
Latin America revenue grew by 8% to £8.3 million.
Improving pork prices and better producer profitability positively impacted revenues in August and September 2024.
Rigorous control of input costs helped maintain gross margins.
Aivlosin® received a new marketing approval in Paraguay.
Late-stage Mycoplasma vaccine projects for poultry progressed towards regulatory submission, with launches planned for 2025.
The company disposed of a non-core equine anti-parasitic product for £1.0 million.
Outlook
The Group expects a stronger second half due to the typically increased demand for Aivlosin® during the Northern Hemisphere winter.
The Board remains confident that full-year profitability will be in line with market consensus.
The Group will continue to invest in its R&D pipeline and pursue options to realize value.
The Board looks forward to reporting full-year numbers in line with revised market expectations.
YearGroup RevenueGross MarginAdjusted EBITDALoss per ShareCash Generated by OperationsCash Balances
H1 2024£33.2 million40.3%£0.4 million2.50p£0.8 million£18.3 million
H1 2023£38.0 million40.8%£0.7 million1.93p£0.7 million£20.6 million
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 2
EAH 11:31
Eco Animal Health Group Plc
Share Purchase by Executive Director
EAH 06:01
Eco Animal Health Group Plc
Results for the Six Months Ended 30 September 2024
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
Here is a summary of the financial report for Eco Animal Health Group plc for the six months ended September 30, 2024
Performance Highlights
Group revenue decreased by 13% to £33.2 million, with a 9% decrease on a constant currency basis.
Gross margins remained relatively stable at 40.3%, compared to 40.8% in the previous year.
Adjusted <mark style="background-coloryellow">EBIT</mark>DA stood at £0.4 million, down from £0.7 million in the same period last year.
Loss per share was 2.50p, compared to a loss per share of 1.93p in the first half of 2023.
Cash generated by operations before working capital increased to £0.8 million.
Cash balances decreased to £18.3 million.
Operational Highlights
Revenue in the USA and Canada increased by 5% to £8.6 million.
Latin America revenue grew by 8% to £8.3 million.
Improving pork prices and better producer profitability positively impacted revenues in August and September 2024.
Rigorous control of input costs helped maintain gross margins.
Aivlosin® received a new marketing approval in Paraguay.
Late-stage Mycoplasma vaccine projects for poultry progressed towards regulatory submission, with launches planned for 2025.
The company disposed of a non-core equine anti-parasitic product for £1.0 million.
Outlook
The Group expects a stronger second half due to the typically increased demand for Aivlosin® during the Northern Hemisphere winter.
The Board remains confident that full-year profitability will be in line with market consensus.
The Group will continue to invest in its R&D pipeline and pursue options to realize value.
The Board looks forward to reporting full-year numbers in line with revised market expectations.
YearGroup RevenueGross MarginAdjusted EBITDALoss per ShareCash Generated by OperationsCash Balances
H1 2024£33.2 million40.3%£0.4 million2.50p£0.8 million£18.3 million
H1 2023£38.0 million40.8%£0.7 million1.93p£0.7 million£20.6 million

Today's AI

Today's AI Starts With News

1 live catalyst is opening Today’s AI for EAH.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2024-12-02 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1 Today
Front Of Desk
Eco Animal Health Group Plc has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
11:31 Today's Catalyst Share Purchase by Executive Director
Single-Ticker Today's AI
EAH signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Eco Animal Health Group Plc. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full EAH Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for EAH on 2024-12-02.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
66.1M
Enterprise Value
52.6M
Public Float
88.6
Broker Target
179.167
Shares Out
67.1M
Long Interest
100
Short Interest
0
Exchange
LSE
Currency Code
GBX
ISIN
GB0032036807
Market
LSE - AIM
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for EAH.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2024-12-02 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Eco Animal Health Group Plc has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
11:31 Today's Alert Share Purchase by Executive Director
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2021-09-23
Earnings Date
2025-11-26
Net Debt
-21.2M
Cash
25.0M
EPS
0.04
Net Income
1.7M
Revenue
79.6M
Enterprise Value
52.6M
Trailing PE
24.5
Forward PE
26.0417
Price Sales TTM
0.7707
Price Book MRQ
0.7876
EV Revenue
0.6197
EV EBITDA
5.5088
Financial Forecastist

Worsening financial engine

Revenue is accelerating +3.7% against the prior comparable period. Net margin is expanding by 2.5 pts. Net debt is coming down +17.4%.

Revenue +3.7% Net Income -72.2% FCF -138.5% Current Ratio 3.73x Forward Rev 0
Worsening
Quarter Revenue
39.4M
+3.7%
vs prior comparable quarter
Net Margin
-0.9%
+2.5 pts
profitability pulse
Free Cash Flow
-1.1M
-138.5%
cash conversion
Net Debt / EBITDA
-5.3x
-17.4%
lower is cleaner
Revenue Engine

Latest quarter printed 39.4M with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at -363.0K and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 18.6M while net debt is -13.6M. The leverage stack is cleaning up.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q4 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q2 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q4 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
86.0M
Revenue Path
0.03
EPS / Earnings
Growth cue -0.1%
FY 2027
Consensus
89.3M
Revenue Path
0.03
EPS / Earnings
Growth cue +0.1%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q3 2025 39.4M -363.0K -1.1M -13.6M
Q1 2025 46.4M 3.4M 9.8M -21.2M
Q3 2024 33.2M -1.7M 452.0K -14.6M
Q1 2024 51.4M 2.4M 4.6M -18.3M
Q3 2023 38.0M -1.3M 2.8M -16.4M
Q1 2023 50.5M -317.0K 10.7M -17.2M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 79.6M 1.7M 7.3M 5.4M
FY 2024 89.4M 1.0M 6.5M 4.9M
FY 2023 85.3M 1.0M 7.4M 9.9M
FY 2022 82.2M -686.0K 3.6M -3.4M
FY 2021 105.6M 7.3M 18.6M 10.9M

Structure DNA

Market Structure DNA

Balanced Structure profile with trend mixed

Price is 74.1% through the 52-week range, +0.4% vs 50DMA and +8.6% vs 200DMA. 82.4% of the register is locked by institutions and insiders, leaving 17.6% free float. Capital rhythm reads semi-annual with forward yield near 0.0% and payout around 0.0%.

Trend mixed Institutional gravity Moderate income rhythm As Of 2026-04-19
Balanced Structure
Structure Score
67.0 / 100
Balanced Structure
Trend Stack
+0.4% / +8.6%
vs 50DMA / 200DMA
52W Position
74.1%
auction position inside the yearly range
Ownership Lock
82.4%
70.6% institutions | 11.8% insiders
Pressure Pocket
17.6% free float
Vendor short-float fields were not supplied
Capital Rhythm
Semi-Annual
Yield 0.0% | payout 0.0%
Trend Runway

Implied spot is 100.10 with the stock +0.4% vs 50DMA and +8.6% vs 200DMA. The tape is sitting 74.1% through the 52-week range, which frames the regime as trend mixed.

Ownership Register

Institutions hold about 70.6% and insiders about 11.8%, locking roughly 82.4% of the register and leaving 17.6% in free float. That reads as institutional gravity.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads semi-annual with 1 event(s) in the last full year, a five-year average of 2.0, and stability score 60.0/100. Forward yield sits near 0.0% while payout is around 0.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Semi-Annual
Year Dividend Count Context
2021 1 Full year
2019 2 Full year
2018 3 Full year
2017 2 Full year
2016 2 Full year
2015 2 Full year
2014 1 Full year
2013 1 Full year

Structure Facts

Live Snapshot
Implied Spot
100.10
derived from market cap / shares
52W High
116.90
upper auction edge
52W Low
52.11
lower auction edge
Beta
0.05
volatility character
Shares Out
67.1M
fully diluted count
Shares Float
59.4M
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
2021-09-23
-1669 day(s) to ex-date
Dividend Pay
-
payment date not supplied
Last Split
3:1
2002-10-18

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
26.9466
Institutions As Of
2026-01-19
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
3
Sale Director Dealing
0
Purchase TR1
3
Sale TR1
2
Broker Coverage Rows
0
Institution Holders Tracked
3
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for EAH, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2024-12-02 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Eco Animal Health Group Plc has fresh news flow live now, so the tape is framing the chart workspace below.
11:31 Today's Catalyst Share Purchase by Executive Director
AI Charts Studio
EAH Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2024-12-02 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast 46.53%
RSI Gauge
Price Change
AI Forecast